Lite Fit USA — Class I drug recall D-1534-2014
Terminated recall by Bacai Inc. Dba Ky Duyen House, reported 2014-08-20. Marketed Without an Approved NDA/ANDA: Bacai, Inc. DBA Ky Duyen House is voluntarily recalling Lite Fit USA, l
| Recall number | D-1534-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Bacai Inc. Dba Ky Duyen House, Fountain Valley, CA, United States |
| Recall initiated | 2014-04-30 |
| Classified | 2014-08-08 |
| Reported by FDA | 2014-08-20 |
| Terminated | 2015-02-10 |
| Quantity | 14,040 softgel |
| Reason classes | undeclared allergen, unapproved product |
| Lot numbers | 05/17, 13165 |
Product
Lite Fit USA, For Men & Women, Extreme Fat Burner, Suppresses Appetite, Boosts Metabolism, Limits Fat Absorption, Increases Energy, Prevents lipid formation by limiting fat absorption 30 pills /Bottle, Distributed by: Bacai, INC. www.litefitusa.com
Reason for recall
Marketed Without an Approved NDA/ANDA: Bacai, Inc. DBA Ky Duyen House is voluntarily recalling Lite Fit USA, lot 13165, due to undeclared sibutramine, making it an unapproved new drug.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1534-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.